Shahenda El‐Naggar

3.2k total citations
20 papers, 539 citations indexed

About

Shahenda El‐Naggar is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Shahenda El‐Naggar has authored 20 papers receiving a total of 539 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Genetics. Recurrent topics in Shahenda El‐Naggar's work include Glioma Diagnosis and Treatment (5 papers), Chromatin Remodeling and Cancer (3 papers) and RNA modifications and cancer (3 papers). Shahenda El‐Naggar is often cited by papers focused on Glioma Diagnosis and Treatment (5 papers), Chromatin Remodeling and Cancer (3 papers) and RNA modifications and cancer (3 papers). Shahenda El‐Naggar collaborates with scholars based in Egypt, United States and Japan. Shahenda El‐Naggar's co-authors include Douglas C. Dean, Yongqing Liu, Douglas S. Darling, Yujiro Higashi, Sham S. Kakar, Jason Chesney, Brian F. Clem, M. Shaheer Malik, Hui Shao and Mariusz Z. Ratajczak and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Molecular and Cellular Biology.

In The Last Decade

Shahenda El‐Naggar

20 papers receiving 531 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shahenda El‐Naggar Egypt 10 337 225 113 70 60 20 539
Karin Zins Austria 13 399 1.2× 289 1.3× 125 1.1× 33 0.5× 52 0.9× 22 806
Katharina Schlereth Germany 8 474 1.4× 290 1.3× 153 1.4× 35 0.5× 56 0.9× 14 757
Diane D. Mao United States 11 242 0.7× 150 0.7× 104 0.9× 128 1.8× 46 0.8× 16 482
Kouichi Tabu Japan 14 332 1.0× 268 1.2× 134 1.2× 124 1.8× 88 1.5× 30 629
Ihsan Chrifi Netherlands 15 285 0.8× 83 0.4× 103 0.9× 40 0.6× 78 1.3× 21 570
Peter Mercado United States 7 290 0.9× 227 1.0× 133 1.2× 21 0.3× 72 1.2× 8 669
Gary McIntosh United Kingdom 8 191 0.6× 249 1.1× 51 0.5× 75 1.1× 77 1.3× 9 491
Andrew S. Gilder United States 13 276 0.8× 79 0.4× 147 1.3× 53 0.8× 51 0.8× 16 517
Chaomei Xiang United States 11 369 1.1× 90 0.4× 120 1.1× 62 0.9× 30 0.5× 15 538
Anant Vinjamoori United States 6 218 0.6× 138 0.6× 91 0.8× 71 1.0× 104 1.7× 7 425

Countries citing papers authored by Shahenda El‐Naggar

Since Specialization
Citations

This map shows the geographic impact of Shahenda El‐Naggar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shahenda El‐Naggar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shahenda El‐Naggar more than expected).

Fields of papers citing papers by Shahenda El‐Naggar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shahenda El‐Naggar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shahenda El‐Naggar. The network helps show where Shahenda El‐Naggar may publish in the future.

Co-authorship network of co-authors of Shahenda El‐Naggar

This figure shows the co-authorship network connecting the top 25 collaborators of Shahenda El‐Naggar. A scholar is included among the top collaborators of Shahenda El‐Naggar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shahenda El‐Naggar. Shahenda El‐Naggar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Elshoky, Hisham A., et al.. (2024). LC3A-mediated autophagy elicits PERK-eIF2α-ATF4 axis activation and mitochondrial dysfunction: Exposing vulnerability in aggresome-positive cancer cells. Journal of Biological Chemistry. 300(6). 107398–107398. 3 indexed citations
2.
Magdeldin, Sameh, et al.. (2024). Epigenetic silencing of ZIC4 unveils a potential tumor suppressor role in pediatric choroid plexus carcinoma. Scientific Reports. 14(1). 21293–21293. 2 indexed citations
3.
Magdeldin, Sameh, Masayasu Okada, Yoshihiro Tsukamoto, et al.. (2024). Multi-omics analyses of choroid plexus carcinoma cell lines reveal potential targetable pathways and alterations. Journal of Neuro-Oncology. 166(1). 27–38. 1 indexed citations
4.
Ghoneimy, Ahmed El, et al.. (2023). Comparative Shotgun Proteomics Reveals the Characteristic Protein Signature of Osteosarcoma Subtypes. Cells. 12(17). 2179–2179. 3 indexed citations
5.
Taha, Hala, Mohamed Soudy, Aya Osama, et al.. (2021). Aggresomes predict poor outcomes and implicate proteostasis in the pathogenesis of pediatric choroid plexus tumors. Journal of Neuro-Oncology. 152(1). 67–78. 7 indexed citations
6.
Refaat, Amal, et al.. (2020). Histone H3K27M Mutation Overrides Histological Grading in Pediatric Gliomas. Scientific Reports. 10(1). 8368–8368. 45 indexed citations
7.
Kebudi, Rejin, Nisreen Amayiri, Malak Abedalthagafi, et al.. (2020). Position paper: Challenges and specific strategies for constitutional mismatch repair deficiency syndrome in low‐resource settings. Pediatric Blood & Cancer. 67(8). e28309–e28309. 12 indexed citations
8.
El‐Naggar, Shahenda, et al.. (2020). Transcriptomic Analysis Revealed an Emerging Role of Alternative Splicing in Embryonal Tumor with Multilayered Rosettes. Genes. 11(9). 1108–1108. 2 indexed citations
9.
Taha, Hala, et al.. (2019). Association of Aggresomes with Survival Outcomes in Pediatric Medulloblastoma. Scientific Reports. 9(1). 12605–12605. 7 indexed citations
10.
El‐Naggar, Shahenda, et al.. (2019). Structure-based design generated novel hydroxamic acid based preferential HDAC6 lead inhibitor with on-target cytotoxic activity against primary choroid plexus carcinoma. Journal of Enzyme Inhibition and Medicinal Chemistry. 34(1). 1062–1077. 14 indexed citations
11.
Taha, Hala, et al.. (2017). LC3A Silencing Hinders Aggresome Vimentin Cage Clearance in Primary Choroid Plexus Carcinoma. Scientific Reports. 7(1). 8022–8022. 15 indexed citations
12.
Gad, Ahmed Z., Shahenda El‐Naggar, & Nabil Ahmed. (2016). Realism and pragmatism in developing an effective chimeric antigen receptor T-cell product for solid cancers. Cytotherapy. 18(11). 1382–1392. 4 indexed citations
13.
El‐Naggar, Shahenda, et al.. (2015). Armed Hunter Killers: Discerning the Role of Adoptive T-Cell Transfer for Glioblastoma. Immunotherapy. 7(5). 481–485. 5 indexed citations
14.
Taha, Hala, et al.. (2015). Incidence of kiaa1549‐braf fusion gene in Egyptian pediatric low grade glioma. SHILAP Revista de lepidopterología. 4(1). 10–10. 9 indexed citations
15.
Liu, Yongqing, Brian F. Clem, Ewa Zuba‐Surma, et al.. (2009). Mouse Fibroblasts Lacking RB1 Function Form Spheres and Undergo Reprogramming to a Cancer Stem Cell Phenotype. Cell stem cell. 4(4). 336–347. 76 indexed citations
16.
El‐Naggar, Shahenda, Yongqing Liu, & Douglas C. Dean. (2009). Mutation of the Rb1 Pathway Leads to Overexpression of mTor, Constitutive Phosphorylation of Akt on Serine 473, Resistance to Anoikis, and a Block in c-Raf Activation. Molecular and Cellular Biology. 29(21). 5710–5717. 39 indexed citations
17.
Liu, Yongqing, Shahenda El‐Naggar, Douglas S. Darling, Yujiro Higashi, & Douglas C. Dean. (2008). Zeb1 links epithelial-mesenchymal transition and cellular senescence. Development. 135(3). 579–588. 243 indexed citations
18.
Liu, Yongqing, Shahenda El‐Naggar, Brian F. Clem, Jason Chesney, & Douglas C. Dean. (2008). The Rb/E2F pathway and Ras activation regulate RecQ helicase gene expression. Biochemical Journal. 412(2). 299–306. 14 indexed citations
19.
El‐Naggar, Shahenda, M. Shaheer Malik, & Sham S. Kakar. (2007). Small interfering RNA against PTTG: A novel therapy for ovarian cancer. International Journal of Oncology. 31(1). 137–43. 26 indexed citations
20.
El‐Naggar, Shahenda, Mohammad Tariq Malik, Alvin W. Martin, et al.. (2007). Development of cystic glandular hyperplasia of the endometrium in Mullerian inhibitory substance type II receptor–pituitary tumor transforming gene transgenic mice. Journal of Endocrinology. 194(1). 179–191. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karin Zins Breakdown of academic impact, for papers by Katharina Schlereth Breakdown of academic impact, for papers by Diane D. Mao Breakdown of academic impact, for papers by Kouichi Tabu Breakdown of academic impact, for papers by Ihsan Chrifi Breakdown of academic impact, for papers by Peter Mercado Breakdown of academic impact, for papers by Gary McIntosh Breakdown of academic impact, for papers by Andrew S. Gilder Breakdown of academic impact, for papers by Chaomei Xiang Breakdown of academic impact, for papers by Anant Vinjamoori
Rankless by CCL
2026